Markets:

Overview

News

Currencies

International

Treasuries

Vera Therapeutics, Inc. - Class A Common Stock (NQ:VERA)

37.92 -0.51 (-1.33%)

Streaming Delayed Price Updated: 3:06 PM EDT, Jun 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vera Therapeutics, Inc. - Class A Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday ↗

November 10, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Recap: Vera Therapeutics Q3 Earnings ↗

November 09, 2023

Via Benzinga

Vera Therapeutics Provides Business Update and Reports Third Quarter Financial Results

November 09, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Presents Positive Data from Phase 2b ORIGIN Study Showing Resolution of Hematuria in Majority of Patients at the American Society of Nephrology Kidney Week 2023

November 04, 2023

From Vera Therapeutics

Via GlobeNewswire

Recap: Vera Therapeutics Q1 Earnings ↗

May 11, 2023

Via Benzinga

Vera Therapeutics Scheduled to Present at November Investor Conferences

October 30, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics to Present Three Posters at the American Society of Nephrology Kidney Week 2023 Annual Meeting

October 13, 2023

From Vera Therapeutics

Via GlobeNewswire

Why Shares of Vera Therapeutics Jumped Tuesday ↗

September 26, 2023

The stock bounced back Tuesday from a three-month low it hit on Monday.

Via The Motley Fool

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 26, 2023

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...

Via Benzinga

Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday ↗

September 26, 2023

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Vera Therapeutics Scheduled to Present at September Investor Conferences

August 31, 2023

From Vera Therapeutics

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023 ↗

August 16, 2023

Via Benzinga

Vera Therapeutics Provides Business Update and Reports Second Quarter Financial Results

August 10, 2023

From Vera Therapeutics

Via GlobeNewswire

Around $8.5M Bet On Eagle Bulk Shipping? Check Out These 4 Stocks Insiders Are Buying ↗

June 23, 2023

Although US stocks closed mostly higher on Thursday, there were a few notable insider trades.

Via Benzinga

Why Shares of Vera Therapeutics Jumped Tuesday ↗

June 20, 2023

The company announced early phase 2 trials information regarding its lead therapy.

Via The Motley Fool

Vera Therapeutics Stock Is Trading Higher Today - Here's Why ↗

June 20, 2023

On Saturday, Vera Therapeutics Inc (NASDAQ: VERA) announced that the Phase 2b ORIGIN trial of atacicept for the treatment of IgA nephropathy (IgAN) met its primary and key secondary endpoints, with...

Via Benzinga

DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesday ↗

June 20, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

2 Surging Healthcare Stocks With More Fuel in the Tank ↗

June 20, 2023

These stocks climbed 74% and 78% over the past month and there could be more gains ahead.

Via The Motley Fool

Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress

June 17, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics to Host Presentation of Week 36 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN

June 15, 2023

From Vera Therapeutics

Via GlobeNewswire

Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 15, 2023

Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 14, 2023

Via Benzinga

Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 12, 2023

Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord.

Via Benzinga

Why Shares of Vera Therapeutics Are Soaring Monday ↗

June 12, 2023

The company, which specializes in autoimmune disorders affecting the kidney, benefited from a renewed interest in kidney therapies.

Via The Motley Fool

US Stocks Open Higher; Nasdaq Rises Over 50 Points ↗

June 12, 2023

U.S. stocks traded higher this morning, with Nasdaq Composite gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.21% to 33,948.78 while the NASDAQ rose 0.47% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 12, 2023

Via Benzinga

7 Stocks That Wall Street Analysts Are Loving in June ↗

June 11, 2023

Sometimes, it’s better to get your ideas from the experts. Thus, if you lack time, these top analyst recommend stocks could be enticing.

Via InvestorPlace

Vera Therapeutics to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference

June 08, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Initiates Pivotal Phase 3 (ORIGIN 3) Clinical Trial of Atacicept for the Treatment of IgA Nephropathy (IgAN)

June 07, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Provides Business Update and Reports First Quarter Financial Results

May 11, 2023

From Vera Therapeutics

Via GlobeNewswire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.